Quest Diagnostics posts a profit increase despite sales slip
Quest Diagnostics Inc. (NYSE:DGX) posted profits of $198 million, or $1.13 per diluted share, on sales of $1.87 billion during the three months ended Sept. 30. That compares with profits of $192 million, or $1.02 per diluted share, on sales of $1.90 billion during the same period last year.
Read more

Alcon’s third-quarter sales rise 9 percent, earnings fall
Alcon Inc. (NYSE:ACL) posted profits of $446 million, or $1.47 per diluted share, on sales of $1.76 billion during the three months ended Sept. 30. That compares with profits of $515 million, or $1.71 per diluted share, on sales of $1.61 billion during the same period last year.
Read more

Vascular Solutions announces record third-quarter results; net revenue increases 15% to $19.9 million
Vascular Solutions Inc. (NSDQ:VASC) posted profits of $1.5 million, or 9 cents per diluted share, on sales of $19.9 million during the three months ended Sept. 30. That compares with profits of $1.4 million, also 9 cents per diluted share, on sales of $17.2 million during the same period last year.
Read more